Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-10-17 to 2024-10-18
Current total value of award: $6282.24
Description: 4566133535!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML